IDEN PHARMA LTD

Company Registration Number:
07316232 (England and Wales)

Unaudited micro entity accounts for the year ended 31 July 2023

Period of accounts

Start date: 01 August 2022

End date: 31 July 2023

IDEN PHARMA LTD

Contents of the Financial Statements

for the Period Ended 31 July 2023

Company Information - 3
Profit and Loss Account - 4
Balance sheet - 5
Footnotes to the Balance Sheet - 7

IDEN PHARMA LTD

Company Information

for the Period Ended 31 July 2023




Registered office: 13
Empress Mews
London
England
SE5 9BT
Company Registration Number: 07316232 (England and Wales)

IDEN PHARMA LTD

Profit and Loss Account

for the Period Ended 31 July 2023


2023
£

2022
£
Turnover 63,100 -
Income from coronavirus (COVID-19) business support grants 0 -
Cost of Materials ( 1,299 ) -
Other charges ( 65,872 ) -
Profit or (Loss) for Period ( 4,071 ) -

IDEN PHARMA LTD

Balance sheet

As at 31 July 2023


2023
£

2022
£
Current assets: 1,092 977
Creditors: amounts falling due within one year: ( 1,185 ) ( 3,221 )
Net current assets (liabilities): ( 93 ) ( 2,244 )
Total assets less current liabilities: ( 93 ) ( 2,244 )
Creditors: amounts falling due after more than one year: ( 6,411 ) ( 4,611 )
Provision for liabilities: ( 4,424 )
Total net assets (liabilities): ( 10,928 ) ( 6,855 )
Capital and reserves: ( 10,928 ) ( 6,855 )

IDEN PHARMA LTD

Balance sheet continued

For the year ending 31 July 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 1 February 2024
And Signed On Behalf Of The Board By:

Name: Neil Graham Oughton
Status: Director

The notes form part of these financial statements

IDEN PHARMA LTD

Footnotes to the Financial Statements

for the Period Ended 31 July 2023

  • 1. Employee Information

    Average number of employees: 0

IDEN PHARMA LTD

Footnotes to the Financial Statements

for the Period Ended 31 July 2023

  • 2. Off balance sheet disclosure

    No